VivoSim Labs (VIVS) EBT (2010 - 2026)

VivoSim Labs has reported EBT for 17 years, with the latest figure at -$2.7 million in Q2 2026.

• On a quarterly basis, EBT rose 3.8% year-over-year to -$2.7 million in Q2 2026; TTM through Jun 2026 was -$11.1 million, a 7.2% increase from a year earlier, with the FY2026 full-year figure at -$11.2 million, up 10.04% from the prior year.
• EBT was -$2.7 million for Q2 2026 at VivoSim Labs, up from -$3.2 million in the prior quarter.
• The five-year high for EBT was -$1.9 million in Q1 2022, with the low at -$7.6 million in Q1 2023.
• Average EBT over 5 years is -$3.4 million, with a median of -$3.2 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2024: EBT tumbled 297.8% in 2023, then soared 59.94% in 2024.
• Over 5 years, EBT stood at -$3.2 million in 2022, then fell by 12.06% to -$3.6 million in 2023, then advanced by 4.36% to -$3.4 million in 2024, then rose by 21.93% to -$2.7 million in 2025, then decreased by 1.64% to -$2.7 million in 2026.
• The last three EBT figures came in at -$2.7 million (Q2 2026), -$3.2 million (Q1 2026), and -$2.7 million (Q4 2025), per Business Quant data.